Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
**Immunoglobulin heavy joining 3 pseudogene (IGHJ3P)** is a non-functional, pseudogene member of the immunoglobulin heavy joining (IGHJ) gene segment family found in the immunoglobulin heavy-chain locus. Unlike functional IGHJ genes that are critical components for antibody gene rearrangement during B cell development, pseudogenes such as IGHJ3P do not encode active gene products and are not involved in immunological signaling, antigen recognition, or V(D)J recombination. The presence of “P” in the gene symbol and designation as a pseudogene means it is not expressed as a functional protein and does not serve as a therapeutic target[2]. **Key points:** - IGHJ3P is a **pseudogene** and not a functional receptor, enzyme, transporter, or transcription factor. - It does not play a direct biological or disease role. - It is not a drug target and has no mechanism of action, drug interactions, biomarker applications, or specific safety concerns associated with it. - Its listing under possible target names is likely mistaken because it is not a gene product with biological activity or therapeutic interest[2].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Immunoglobulin heavy joining 3 pseudogene (IGHJ3P).